You are here: Industry Insights > Drug

News List

Novartis pays €95M to bag dermatitis drug from Galapagos, MorphoSys fiercebiotech
July 20, 2018
Novartis is set to pay €95 million ($110 million) upfront for the global rights to Galapagos and MorphoSys’ anti-IL-17C antibody MOR106. The deal positions Novartis to take MOR106 forward in atopic dermatitis and other indications, handing over up to €850
MSD's ulcerative colitis drug scores expanded indication in Europe pharmafile
July 17, 2018
New Jersey-based multinational MSD have announced that the European Commission (EC) has approved Simponi (golimumab) for early dose optimisation in ulcerative colitis (UC) for patients with body weight less than 80kg who do not respond adequately to induc
Zogenix’ drug cuts seizures in Dravet syndrome pharmatimes
July 16, 2018
The study met its primary endpoint, demonstrating that the drug is superior to placebo as adjunctive therapy to stiripentol in the treatment of children and young adults with the condition, a difficult-to-treat form of childhood-onset epilepsy.
Boehringer expands drug manufacturing capabilities in China pharmaceutical-technology
July 12, 2018
Boehringer Ingelheim has added a new filling line to its Oasis facility in Shanghai, China in order to expand and consolidate its contract drug manufacturing capabilities.
EUSA Pharma’s tivozanib drug approved for kidney cancer in Scotland pharmaceutical-technology
July 12, 2018
Scotland’s pharmaceutical regulatory authority the Scottish Medicines Consortium (SMC) has recommended Jazz Pharmaceutical spin-off EUSA Pharma’s fotivda (tivozanib) for the first line treatment of adults with advanced renal cell carcinoma (RCC).
Blood pressure drug verapamil may help type 1 diabetics pharmaceutical-technology
July 12, 2018
A human clinical trial has found that common blood pressure drug called verapamil can decrease insulin requirements and hypoglycaemic episodes in adults with recent onset type 1 diabetes.
FDA to Encourage More Informative Drug Labeling americanpharmaceuticalreview
July 11, 2018
The U.S. Food and Drug Administration (FDA) issued a draft guidance to provide recommendations for consideration when drafting the Indications and Usage section of human drug and biological product labeling.
Gemphire sparkles on third trial win for lead drug gemcabene fiercebiotech
July 09, 2018
Shares in Gemphire Therapeutics more than doubled after its lead drug gemcabene aced a midstage trial in patients with high triglycerides—setting up a phase 3 program.
After nearly 3 years, FDA lifts hold on Aptose cancer drug fiercebiotech
July 09, 2018
The FDA has lifted a clinical hold on Aptose Biosciences’ APTO-253 almost three years after it stopped the blood cancer program. Aptose is now racing to resume dosing patients with the c-Myc inhibitor in the paused phase 1b study.
The old diabetes drug metformin may find yet another role: reversing lung fibrosis fiercebiotech
July 09, 2018
The drug metformin has been used to control blood sugar in many patients with Type 2 diabetes for more than two decades.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 49 50 Next page